摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Ethylphenoxy)propan-2-one | 1036762-56-7

中文名称
——
中文别名
——
英文名称
1-(2-Ethylphenoxy)propan-2-one
英文别名
——
1-(2-Ethylphenoxy)propan-2-one化学式
CAS
1036762-56-7
化学式
C11H14O2
mdl
MFCD12145442
分子量
178.231
InChiKey
ANSFUNRJJFRVTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Discovery of amino-acetonitrile derivatives, a new class of synthetic anthelmintic compounds
    作者:Pierre Ducray、Noëlle Gauvry、François Pautrat、Thomas Goebel、Joerg Fruechtel、Yves Desaules、Sandra Schorderet Weber、Jacques Bouvier、Trixie Wagner、Olivier Froelich、Ronald Kaminsky
    DOI:10.1016/j.bmcl.2008.03.071
    日期:2008.5
    A new series of amino-acetonitrile derivatives (AAD) have been discovered that exhibit high anthelmintic activity against parasitic nematode species such as Haemonchus contortus and Trichostrongylus colubriformis. Significantly, these compounds also demonstrate activity against nematode strains resistant to the currently available broad-spectrum anthelmintics. The discovery, synthesis, structure-activity
    已经发现了一系列新的氨基乙腈衍生物(AAD),它们对寄生的线虫物种(例如,弯扭线虫和棒状毛线虫)表现出较高的驱虫活性。重要的是,这些化合物还显示出抗线虫菌株的活性,该菌株对目前可用的广谱驱虫药具有抗性。介绍了其发现,合成,构效关系和生物学结果。
  • COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
    申请人:SHY Therapeutics LLC
    公开号:US20170174699A1
    公开(公告)日:2017-06-22
    Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
    本文提供了抑制MAPK磷酸化的化合物,因此可用于治疗癌症和炎症性疾病的组合物和方法。
  • Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
    申请人:Shy Therapeutics LLC
    公开号:US11000515B2
    公开(公告)日:2021-05-11
    Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    本文提供了通过化合物与 Ras 超家族蛋白(在某些情况下包括 K-Ras 及其突变体)的 GTP 结合结构域结合,治疗涉及 Ras 超家族信号异常的癌症、炎症性疾病、rasopathies 和纤维化疾病的方法和组合物,以及检测此类组合物的新方法。
  • COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE
    申请人:Shy Therapeutics LLC
    公开号:US20200061037A1
    公开(公告)日:2020-02-27
    Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
  • [EN] COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU CANCER ET DE MALADIES INFLAMMATOIRES
    申请人:SHY THERAPEUTICS LLC
    公开号:WO2017112777A1
    公开(公告)日:2017-06-29
    Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are compositions and methods for treating cancer and inflammatory disease.
查看更多